key: cord-0962391-0l5ca6im authors: Pratelli, Annamaria; Lucente, Maria Stella; Mari, Viviana; Cordisco, Marco; Sposato, Alessio; Capozza, Paolo; Lanave, Gianvito; Martella, Vito; Buonavoglia, Alessio title: A simple pooling salivary test for SARS-CoV-2 diagnosis: A Columbus’ egg? date: 2021-09-21 journal: Virus Res DOI: 10.1016/j.virusres.2021.198575 sha: b0dba350fc4d381b636043bf6b1d0c55eed3b6fc doc_id: 962391 cord_uid: 0l5ca6im Saliva is an appropriate specimen for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) diagnosis. The possibility of pooling samples of saliva, using non-invasive bibula strips for sampling, was explored employing Bovine coronavirus (BCoV) spiked saliva. In laboratory, up to 30 saliva-soaked strips were pooled in a single tube with 2 mL of medium. After quick adsorption with the medium and vortexing, the liquid was collected and tested with a quantitative molecular assay to quantify viral RNA genome copies. On testing of single and pooled strips, the difference between the median threshold cycles (Ct) value of test performed on the single positive saliva sample and the median Ct value obtained on the pool of 30 strips, was 3.21 cycles. Saliva pooling with bibula strips could allow monitoring of COVID-19 on a large scale, reducing costs for the health bodies in terms of medical material and skilled personnel. Finally, saliva sampling is noninvasive and less traumatic than nasopharyngeal swabs and can be self-collected. The COVID-19 pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) started spreading in the first months of 2020 and was characterized by multiple waves of infections and deaths globally, with critical issues becoming apparent due to inadequate management strategies (Falzone et al., 2021) . Despite the optimism deriving from the approval of vaccines by the health authorities, economic disparities and/or political decisions have generated major differences in terms of vaccines coverage and of access to SARS-CoV-2 testing, affecting the control of COVID-19 among the various countries (Rajendrakumar et al., 2021) . Since the beginning of the pandemic, health authorities were urged to achieve the most important goal of developing effective diagnostic tests for rapid and accurate identification of SARS-CoV-2 in the infected patients, thus limiting the risk of contagion (Ji et al., 2020) . The gold standard test for COVID-19 diagnosis is the collection of deep nasopharyngeal swabs (NPS) followed by molecular testing, such as real-time polymerase chain reaction (qPCR), although samples collection of NPS is invasive chiefly for children. This situation has been addressed using innovative approaches (Callahan et al., 2020) , for easier and less invasive sample collection, and for speeding up the screening of group of persons and of large populations (Czumbel et al., 2020) . Recent data support the idea that saliva testing is a valid and practicable test with a number of advantages over NPS when multiple samples need to be tested periodically: i) saliva samples can be self-collected with 4 minimal guidance of healthcare personnel; ii) the procedure is less invasive; iii) it is a more feasible option for repeated or systematic testing (Azzi et al., 2020 In the sample pooling strategy, a set of samples was tested together in a single run. From the 50mL tubes containing the strips, treated as described, 200µL of medium was collected and processed for RNA extraction using the commercial kit QIAamp ® cador ® Pathogen Mini Kit (Qiagen GmbH, Hilden, Germany). The qPCR, based on TaqMan chemistry, was carried out as To develop the saliva pooling approaches that can meet bulk testing demands, a pool of salivary In this study we evaluated a sample pooling strategy for mass screening of groups of individuals, using saliva as sampling material instead of NPSs. The rational for this study relied in the fact that sampling of saliva is considered as reliable as, but easier than sampling with NPS, chiefly for some and proved helpful to screen large numbers of asymptomatic people (Lohse et al., 2020) . Finally, using strips of a costless and common matrix as bibula paper could be an advantage for laboratories in low-income countries and could help decreasing sample processing. The potential advantage of pooling saliva samples was explored with a safe laboratory surrogate In conclusion, the following Salivary sampling proposal is advised: A sterile single test tube and one bibula strip should be provided for each subject (Figure 1a ), who will be requested to self-collect saliva specimens by placing the bibula strip for few seconds (3) (4) (5) sec) inside the mouth (Figure 1b) . This should correspond to about 30µL of saliva absorbed by the strip. Each individual strip should be inserted into the provided test tube, closed and transported to the laboratory at +4°C. After delivery in the laboratory, all the bibula strips of the monitored 10 population group (i.e. classroom, office, or day-care center) will be collected in a single 50mL sterile conical centrifuge tube added with 2mL of DMEM to form a pool of up to 30 strips ( Figure 1c ). Each sample pool will be treated as described above (Figure 1d ). If the sample pool tests negative, no further testing is required. If the sample pool tests positive, re-screening of all individuals of the population group is required to individuate the infected persons. Saliva is a reliable tool to detect SARS-CoV-2 Open development and clinical validation of multiple 3D-printed sample-collection swabs: rapid resolution of a critical COVID-19 testing bottleneck Saliva as a candidate for COVID-19 diagnostic testing: a Meta-Analysis Genotypespecific fluorogenic RT-PCR assays for the detection and quantification of canine coronavirus type I and type II RNA in faecal samples of dogs Detection of bovine coronavirus using a TaqMan-based real-time RT-PCR assay Current and innovative methods for the diagnosis of COVID-19 infection Saliva is a reliable and accessible source for the detection of SARS-CoV-2 New COVID-19 saliva-based test: How good is it compared with the current nasopharyngeal or throat swab test? Detection of COVID-19: A review of the current literature and future perspectives Pooling of samples for testing for SARS-CoV-2 in asymptomatic people Informative Dorfman screening Direct RT-qPCR, Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19 Saliva sample pooling for the detection of SARS-CoV-2 Epidemic landscape and forecasting SARS-CoV-2 in India Risk of SARS-CoV-2 reinfection in a university student population SARS-CoV-2 is detectable using sensitive RNA saliva testing days before viral load reaches detection range of low-sensitivity nasal swab tests Saliva-based PCR tests for SARS-CoV-2 detection Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study Consistent detection of 2019 novel coronavirus in saliva Increased SARS-CoV-2 testing capacity with pooled saliva samples Posterior oropharyngeal saliva for the detection of SARS-CoV-2 Saliva or nasopharyngeal swab specimens for detection of SARS-CoV-2 The Authors are grateful to Carlo Armenise for his excellent assistance and